<p>IHC; immunohistochemistry; ND: not documented.</p><p>Main characteristics and results of the eligible studies.</p
<p>PCR: polymerase chain reaction; Sequenom: mass spectrometry-based genotyping; ddSEQ: direct dideo...
<p>Scoring criteria of Immunohistochemistry (IHC) assay with specific antibodies used in this study....
<p>PB: population-based; HB: hospital-based; a: studies with P<sub>HWE</sub>>0.05; b: studies with P...
<p><i>IHC</i> Immunohistochemistry.</p><p>Characteristics of eligible studies.</p
<p>Characteristics of primary antibodies used in immunohistochemical (IHC) analysis.</p
<p>Abbreviation: NA, not available; NO, number; IHC, immunohistochemistry; RT-PCR, real-time reverse...
<p>NR: none reported; T/C: test group/control group; CLEIA: chemiluminescent enzyme immunoassay.</p>...
<p>NR: Not reported.</p><p>Evaluation of human PD-L1 by immunohistochemistry (IHC) in the selected s...
<p>NA, not available; ELISA, enzyme linked immunosorbent assay; PCR, polymerase chain reaction; TP, ...
<p><sup>a</sup>Tumor stage and percentage of advanced stage(%); NR, Not Reported; CTCs, circulating ...
<p>Summary table of studies included in the meta-analysis. Abbreviations: CI, confidence interval; N...
<p><b>Abbreviations</b>: MRD = matched related donor; MUD = matched unrelated donor; MMD = mismatche...
<p>Note: NR, not report; OS, overall survival.</p><p>Main characteristics of the included studies.</...
<p>Main characteristics of the eligible studies included in the systematic review.</p
<p>Specific study characteristics and the number of studies that possess each characteristic.</p><p>...
<p>PCR: polymerase chain reaction; Sequenom: mass spectrometry-based genotyping; ddSEQ: direct dideo...
<p>Scoring criteria of Immunohistochemistry (IHC) assay with specific antibodies used in this study....
<p>PB: population-based; HB: hospital-based; a: studies with P<sub>HWE</sub>>0.05; b: studies with P...
<p><i>IHC</i> Immunohistochemistry.</p><p>Characteristics of eligible studies.</p
<p>Characteristics of primary antibodies used in immunohistochemical (IHC) analysis.</p
<p>Abbreviation: NA, not available; NO, number; IHC, immunohistochemistry; RT-PCR, real-time reverse...
<p>NR: none reported; T/C: test group/control group; CLEIA: chemiluminescent enzyme immunoassay.</p>...
<p>NR: Not reported.</p><p>Evaluation of human PD-L1 by immunohistochemistry (IHC) in the selected s...
<p>NA, not available; ELISA, enzyme linked immunosorbent assay; PCR, polymerase chain reaction; TP, ...
<p><sup>a</sup>Tumor stage and percentage of advanced stage(%); NR, Not Reported; CTCs, circulating ...
<p>Summary table of studies included in the meta-analysis. Abbreviations: CI, confidence interval; N...
<p><b>Abbreviations</b>: MRD = matched related donor; MUD = matched unrelated donor; MMD = mismatche...
<p>Note: NR, not report; OS, overall survival.</p><p>Main characteristics of the included studies.</...
<p>Main characteristics of the eligible studies included in the systematic review.</p
<p>Specific study characteristics and the number of studies that possess each characteristic.</p><p>...
<p>PCR: polymerase chain reaction; Sequenom: mass spectrometry-based genotyping; ddSEQ: direct dideo...
<p>Scoring criteria of Immunohistochemistry (IHC) assay with specific antibodies used in this study....
<p>PB: population-based; HB: hospital-based; a: studies with P<sub>HWE</sub>>0.05; b: studies with P...
DOI
Add to ORKG